Vivimed Labs Limited (NSE:VIVIMEDLAB)

India flag India · Delayed Price · Currency is INR
6.95
+0.16 (2.36%)
Mar 10, 2026, 11:43 AM IST
Market Cap 562.99M
Revenue (ttm) 1.09B
Net Income (ttm) -243.69M
Shares Out 82.91M
EPS (ttm) -2.94
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 50,396
Average Volume 412,588
Open 7.12
Previous Close 6.79
Day's Range 6.76 - 7.12
52-Week Range 6.72 - 29.40
Beta 0.50
RSI 31.33
Earnings Date Feb 13, 2026

About Vivimed Labs

Vivimed Labs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, specialty chemicals, and retail branded formulations in India. It operates through two segments, Speciality Chemicals Business and Pharma Business. The company provides APIs and intermediates to generic and ethical companies; and branded formulations in therapeutic segments, such as ophthalmic, nutraceuticals, dermatology, and pain, as well as contract manufacturing of capsules and tablets, syrups ... [Read more]

Sector Healthcare
Founded 1988
Employees 586
Stock Exchange National Stock Exchange of India
Ticker Symbol VIVIMEDLAB
Full Company Profile

Financial Performance

In fiscal year 2025, Vivimed Labs's revenue was 1.21 billion, a decrease of -24.15% compared to the previous year's 1.59 billion. Losses were -319.61 million, -29.67% less than in 2024.

Financial Statements

News

There is no news available yet.